路易斯安那州解决了两起CVS/Carmark诉讼案, 指控反竞争做法提高了药品价格, 伤害了独立的药店。 Louisiana settles two CVS/Caremark lawsuits over alleged anti-competitive practices that raised drug prices and hurt independent pharmacies.

路易斯安那州已经解决了针对CVS健康公司及其药店福利经理Caremark的两起联邦诉讼案,指控其反竞争做法伤害了独立的药店和高涨的药品价格。 Louisiana has settled two federal lawsuits against CVS Health and its pharmacy benefit manager, Caremark, over allegations of anti-competitive practices that harmed independent pharmacies and inflated drug prices. 国家声称,Caremark药店报酬不足,引导病人前往CVS所有地点,并使用扩大定价和退款制度,增加费用,特别是胰岛素的费用。 The state claimed Caremark underpaid pharmacies, steered patients to CVS-owned locations, and used spread pricing and rebate systems that increased costs, particularly for insulin. 联邦法官于12月10日驳回了这些案件, 如果不达成最后协议, The cases were dismissed by a federal judge on December 10, with the possibility of reopening if a final agreement isn’t reached. 第三项诉讼仍悬而未决,指控CVS利用客户数据发送政治信息,反对针对其商业模式的立法。 A third lawsuit remains pending, alleging CVS used customer data to send political messages opposing legislation targeting its business model. 结算条款没有披露。 Settlement terms were not disclosed.